IBTA Fundamental Analysis - IBOTTA INC-CL A

Name: IBOTTA INC-CL A (IBTA) Stock
Brand: IBOTTA INC-CL A
Rating: 3 (3 reviews)

Fundamental Rating

IBTA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 96 industry peers in the Media industry. IBTA has an excellent financial health rating, but there are some minor concerns on its profitability. IBTA is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IBTA was profitable.

IBTA had a positive operating cash flow in the past year.

1.2 Ratios

IBTA's Return On Assets of 14.18% is amongst the best of the industry. IBTA outperforms 95.83% of its industry peers.

IBTA has a Return On Equity of 24.50%. This is amongst the best in the industry. IBTA outperforms 92.71% of its industry peers.

Looking at the Return On Invested Capital, with a value of 3.90%, IBTA is in the better half of the industry, outperforming 60.42% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	14.18%
ROE	24.5%
ROIC	3.9%

ROA(3y)-2.02%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IBTA has a Profit Margin of 22.92%. This is amongst the best in the industry. IBTA outperforms 92.71% of its industry peers.

IBTA has a Operating Margin (4.65%) which is in line with its industry peers.

IBTA's Gross Margin of 80.89% is amongst the best of the industry. IBTA outperforms 91.67% of its industry peers.

		Industry Rank	Sector Rank
OM	4.65%
PM (TTM)	22.92%
GM	80.89%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBTA is destroying value.

The number of shares outstanding for IBTA has been increased compared to 1 year ago.

IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.63 indicates that IBTA is not a great score, but indicates only limited risk for bankruptcy at the moment.

IBTA's Altman-Z score of 2.63 is amongst the best of the industry. IBTA outperforms 81.25% of its industry peers.

There is no outstanding debt for IBTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	2.63

ROIC/WACC0.45

WACC8.68%

2.3 Liquidity

A Current Ratio of 2.21 indicates that IBTA has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 2.21, IBTA belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.

A Quick Ratio of 2.21 indicates that IBTA has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 2.21, IBTA belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.21
Quick Ratio	2.21

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IBTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1635.56%, which is quite impressive.

IBTA shows a decrease in Revenue. In the last year, the revenue decreased by -4.42%.

EPS 1Y (TTM)1635.56%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-90.2%

Revenue 1Y (TTM)-4.42%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-15.58%

3.2 Future

IBTA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -25.99% yearly.

IBTA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.38% yearly.

EPS Next Y-48.62%

EPS Next 2Y-75.32%

EPS Next 3Y-25.99%

EPS Next 5YN/A

Revenue Next Year-9.52%

Revenue Next 2Y-4.6%

Revenue Next 3Y-0.38%

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.10, IBTA can be considered very expensive at the moment.

Based on the Price/Earnings ratio, IBTA is valued a bit cheaper than the industry average as 61.46% of the companies are valued more expensively.

Compared to an average S&P500 Price/Earnings ratio of 25.47, IBTA is valued at the same level.

IBTA is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	27.1
Fwd PE	N/A

4.2 Price Multiples

IBTA's Enterprise Value to EBITDA ratio is in line with the industry average.

Based on the Price/Free Cash Flow ratio, IBTA is valued a bit cheaper than 69.79% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	10.38
EV/EBITDA	19.41

4.3 Compensation for Growth

IBTA's earnings are expected to decrease with -25.99% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-75.32%

EPS Next 3Y-25.99%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IBTA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

IBOTTA INC-CL A

NYSE:IBTA (11/20/2025, 1:07:06 PM)

23.31

-1.05 (-4.31%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)11-12 2025-11-12/amc

Earnings (Next)02-26 2026-02-26

Inst Owners52.81%

Inst Owner Change-1.3%

Ins Owners7.1%

Ins Owner Change1.88%

Market Cap662.00M

Revenue(TTM)352.24M

Net Income(TTM)80.75M

Analysts51.43

Price Target29.73 (27.54%)

Short Float %18.42%

Short Ratio6.81

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)777.32%

Min EPS beat(2)-59.33%

Max EPS beat(2)1613.97%

EPS beat(4)3

Avg EPS beat(4)478.27%

Min EPS beat(4)-59.33%

Max EPS beat(4)1613.97%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-3.58%

Min Revenue beat(2)-6.83%

Max Revenue beat(2)-0.34%

Revenue beat(4)1

Avg Revenue beat(4)-3.26%

Min Revenue beat(4)-6.93%

Max Revenue beat(4)1.04%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-1.88%

PT rev (3m)-49.93%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)-99.29%

EPS NY rev (1m)4.68%

EPS NY rev (3m)-91%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-19.42%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-12.2%

Valuation

		Industry Rank	Sector Rank
PE	27.1
Fwd PE	N/A
P/S	1.88
P/FCF	10.38
P/OCF	7.4
P/B	2.01
P/tB	2.01
EV/EBITDA	19.41

EPS(TTM)0.86

EY3.69%

EPS(NY)-0.2

Fwd EYN/A

FCF(TTM)2.25

FCFY9.63%

OCF(TTM)3.15

OCFY13.51%

SpS12.4

BVpS11.61

TBVpS11.61

PEG (NY)N/A

PEG (5Y)N/A

Graham Number14.99

Profitability

		Industry Rank	Sector Rank
ROA	14.18%
ROE	24.5%
ROCE	4.51%
ROIC	3.9%
ROICexc	10.15%
ROICexgc	10.15%
OM	4.65%
PM (TTM)	22.92%
GM	80.89%
FCFM	18.11%

ROA(3y)-2.02%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score7

Asset Turnover0.62

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	330.28%
Cap/Sales	7.29%
Interest Coverage	72.76
Cash Conversion	370.51%
Profit Quality	78.99%
Current Ratio	2.21
Quick Ratio	2.21
Altman-Z	2.63

F-Score7

WACC8.68%

ROIC/WACC0.45

Cap/Depr(3y)126.83%

Cap/Depr(5y)N/A

Cap/Sales(3y)3.09%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)1635.56%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-90.2%

EPS Next Y-48.62%

EPS Next 2Y-75.32%

EPS Next 3Y-25.99%

EPS Next 5YN/A

Revenue 1Y (TTM)-4.42%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-15.58%

Revenue Next Year-9.52%

Revenue Next 2Y-4.6%

Revenue Next 3Y-0.38%

Revenue Next 5YN/A

EBIT growth 1Y-60.28%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year73.06%

EBIT Next 3Y27.99%

EBIT Next 5YN/A

FCF growth 1Y629.68%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y410.29%

OCF growth 3YN/A

OCF growth 5YN/A

IBOTTA INC-CL A / IBTA FAQ

What is the ChartMill fundamental rating of IBOTTA INC-CL A (IBTA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IBTA.

What is the valuation status of IBOTTA INC-CL A (IBTA) stock?

ChartMill assigns a valuation rating of 2 / 10 to IBOTTA INC-CL A (IBTA). This can be considered as Overvalued.

What is the profitability of IBTA stock?

IBOTTA INC-CL A (IBTA) has a profitability rating of 4 / 10.

Can you provide the financial health for IBTA stock?

The financial health rating of IBOTTA INC-CL A (IBTA) is 8 / 10.

IBOTTA INC-CL A (IBTA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

IBOTTA INC-CL A / IBTA FAQ

What is the ChartMill fundamental rating of IBOTTA INC-CL A (IBTA) stock?

What is the valuation status of IBOTTA INC-CL A (IBTA) stock?

What is the profitability of IBTA stock?

Can you provide the financial health for IBTA stock?